Like the proverbial light at the end of the tunnel, vaccine rollout has begun around the world after a long period of COVID-19 distress. From grim and gloom helplessness, a ray hope is at the horizon.
At the time of writing this article, about 14 lakh doses of vaccine had been administered in India, with the world total crossing a staggering 600 lakh doses.
Thankfully no alarming adverse reaction is reported as resulting from the vaccination. In this context, here are some of the frequently asked questions and our response to the same.
How is a vaccine candidate developed?
To continue reading this article...
You have to be a Premium Subscriber
Start your subscription with a free trial
Enjoy unlimited Eighth column, archives and games on
thefederal.com and thefederal.com and many more features.
thefederal.com and thefederal.com and many more features.
You will also be supporting ethical and unbiased journalism.
plans start from Rs. 99
plans start from Rs. 99
